Skip to content

Resources

EmboCept® S DSM 50 µm suspension for injection is an adjuvant in the intra-arterial treatment of inoperable liver tumours and lung tumours in combination with cytostatic agents, the aim of which is to optimise the intra-tumoral drug accumulation.

EmboCept® is a registered trademark of Magle PharmaCept GmbH.